Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palliative radiation therapy.

Andre Konski1, Steven Feigenberg, Edward Chow

  • 1Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. A_Konski@fccc.edu

Seminars in Oncology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer.

Cancer·2025
Same author

Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580.

International journal of radiation oncology, biology, physics·2025
Same author

Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial.

Practical radiation oncology·2024
Same author

Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2024
Same author

Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.

Cancer·2024
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Radiation therapy effectively manages metastatic cancer symptoms, with abbreviated and hypofractionated regimens offering quick palliation. Treatment choice depends on patient performance status and cancer type for optimal symptom relief.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Palliative Care

Background:

  • Radiation therapy is a key tool for managing symptoms in patients with metastatic cancer.
  • Treatment decisions are influenced by patient's Karnofsky performance status (KPS) and cancer characteristics.
  • Abbreviated and hypofractionated radiation regimens are often preferred for rapid symptom relief and reduced patient burden.

Purpose of the Study:

  • To review the role of radiation therapy in palliative care for metastatic cancer.
  • To highlight the benefits of abbreviated and hypofractionated regimens.
  • To discuss the suitability of different radiation strategies based on patient KPS and cancer type.

Main Methods:

  • Literature review of studies on radiation therapy for metastatic disease palliation.

Related Experiment Videos

  • Analysis of treatment outcomes for various hypofractionated and conventional radiation regimens.
  • Evaluation of factors influencing treatment selection, including KPS and cancer site.

    • Main Results:

    • Hypofractionated radiation effectively palliates pain from bone metastases, obstruction in lung cancer, bleeding in gynecologic cancers, and hematuria in bladder cancer.
    • Abbreviated regimens provide rapid palliation, minimizing travel time for patients.
    • Aggressive treatments like whole-brain radiation therapy (WBRT) and stereotactic radiosurgery are options for select patients with good KPS.
    • Radiation is also effective for palliating recurrent cancers previously treated with definitive radiation.

    Conclusions:

    • Radiation therapy is a versatile and effective modality for symptom management in metastatic cancer.
    • Tailoring radiation regimens based on KPS and cancer type optimizes palliative outcomes.
    • Hypofractionated and abbreviated schedules offer significant benefits for patient palliation and quality of life.